{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:05:34Z","timestamp":1788584734459,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12016-015-8476-9","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T06:34:48Z","timestamp":1427178888000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis"],"prefix":"10.1007","volume":"49","author":[{"given":"Nicola","family":"Bassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorella","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ceol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"8476_CR1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","volume":"119","author":"A Doria","year":"2006","unstructured":"Doria A, Iaccarino L, Ghirardello A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700\u2013706","journal-title":"Am J Med"},{"key":"8476_CR2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","volume":"10","author":"A Doria","year":"2010","unstructured":"Doria A, Zen M, Canova M et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10:55\u201360","journal-title":"Autoimmun Rev"},{"key":"8476_CR3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.autrev.2014.01.055","volume":"13","author":"A Doria","year":"2014","unstructured":"Doria A, Gatto M, Zen M, Iaccarino L, Punzi L (2014) Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 13:770\u2013777","journal-title":"Autoimmun Rev"},{"key":"8476_CR4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","volume":"11","author":"OP Rekvig","year":"2012","unstructured":"Rekvig OP, Putterman C, Casu C et al (2012) Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 11:596\u2013603","journal-title":"Autoimmun Rev"},{"key":"8476_CR5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrrheum.2010.56","volume":"6","author":"MC Pickering","year":"2010","unstructured":"Pickering MC, Botto M (2010) Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol 6:490\u2013493","journal-title":"Nat Rev Rheumatol"},{"key":"8476_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1422.025","volume":"1108","author":"Y Shoenfeld","year":"2007","unstructured":"Shoenfeld Y, Szyper-Kravitz M, Witte T et al (2007) Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N. Y. Acad Sci 1108:227\u2013239","journal-title":"Acad Sci"},{"key":"8476_CR7","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","volume":"69","author":"N Bassi","year":"2010","unstructured":"Bassi N, Ghirardello A, Blank M et al (2010) IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 69:1704\u20131710","journal-title":"Ann Rheum Dis"},{"key":"8476_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","volume":"39","author":"OD Ortega-Hernandez","year":"2009","unstructured":"Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Aanaya JM (2009) The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum 39:38\u201354","journal-title":"Semin Arthritis Rheum"},{"key":"8476_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","volume":"67","author":"AJ Nauta","year":"2005","unstructured":"Nauta AJ, de Haij S, Bottazzi B et al (2005) Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 67:543\u2013553","journal-title":"Kidney Int"},{"key":"8476_CR10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10875-013-9879-0","volume":"33","author":"MM Speeckaert","year":"2013","unstructured":"Speeckaert MM, Speeckaert R, Carrero JJ, Vanholder R, Delanghe JR (2013) Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol 33:881\u2013890","journal-title":"J Clin Immunol"},{"key":"8476_CR11","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1177\/0961203312462267","volume":"21","author":"A Doria","year":"2012","unstructured":"Doria A, Gatto M (2012) Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. Lupus 21:1492\u20131496","journal-title":"Lupus"},{"key":"8476_CR12","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/art.20628","volume":"50","author":"American College of Rheumatology Ad Hoc on Systemic Lupus Erythematosus Response Criteria","year":"2004","unstructured":"American College of Rheumatology Ad Hoc on Systemic Lupus Erythematosus Response Criteria (2004) The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 50:3418\u20133426","journal-title":"Arthritis Rheum"},{"key":"8476_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati V, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. JASN 15:241\u2013250","journal-title":"JASN"},{"key":"8476_CR14","first-page":"549","volume":"10","author":"W Bencivelli","year":"1992","unstructured":"Bencivelli W, Vitali C, Isenberg DA et al (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. The European consensus study group for disease activity in SLE. Clin Exp Rheumatol 10:549\u2013554","journal-title":"Clin Exp Rheumatol"},{"key":"8476_CR15","doi-asserted-by":"crossref","first-page":"e45605","DOI":"10.1371\/journal.pone.0045605","volume":"7","author":"M Ceol","year":"2012","unstructured":"Ceol M, Tiralongo E, Baelde HJ et al (2012) Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies. PLoS One 7:e45605","journal-title":"PLoS One"},{"key":"8476_CR16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/annrheumdis-2012-202443","volume":"73","author":"A Doria","year":"2014","unstructured":"Doria A, Amoura Z, Cervera R et al (2014) Annual direct medical costs of active systemic lupus erythematosus in five European countries. Ann Rheum Dis 73:154\u2013160","journal-title":"Ann Rheum Dis"},{"key":"8476_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2007.12.001","volume":"7","author":"S Yung","year":"2008","unstructured":"Yung S, Chan TM (2008) Anti-DNA antibodies in the pathogenesis of lupus nephritis\u2014the emerging mechanisms. Autoimmun Rev 7:317\u2013321","journal-title":"Autoimmun Rev"},{"key":"8476_CR18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.20980","volume":"52","author":"MD Linnik","year":"2005","unstructured":"Linnik MD, Hu JZ, Heilbrunn KR et al (2005) Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 52:1129\u20131137","journal-title":"Arthritis Rheum"},{"key":"8476_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0961203310379871","volume":"20","author":"A Matrat","year":"2011","unstructured":"Matrat A, Veysseyre-Balter C, Trolliet P et al (2011) Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus 20:28\u201334","journal-title":"Lupus"},{"key":"8476_CR20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203311411597","volume":"20","author":"E Akhter","year":"2011","unstructured":"Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M (2011) Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 20:1267\u20131274","journal-title":"Lupus"},{"key":"8476_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2009.04746.x","volume":"1173","author":"RA Sinico","year":"2009","unstructured":"Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G (2009) Anti-C1q autoantibodies in lupus nephritis. Ann N. Y. Acad Sci 1173:47\u201351","journal-title":"Acad Sci"},{"key":"8476_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0961203314547791","volume":"24","author":"AM Orbai","year":"2015","unstructured":"Orbai AM, Truedsson L, Sturfelt G et al (2015) Anti-C1q antibodies in systemic lupus erythematosus. Lupus 24:42\u201349","journal-title":"Lupus"},{"key":"8476_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/ard.2006.065425","volume":"66","author":"C Grootscholten","year":"2007","unstructured":"Grootscholten C, Dieker JW, McGrath FD et al (2007) A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine\/methylprednisolone. Ann Rheum Dis 66:693\u2013696","journal-title":"Ann Rheum Dis"},{"key":"8476_CR24","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/art.30401","volume":"63","author":"Y Katsumata","year":"2011","unstructured":"Katsumata Y, Miyake K, Kawaguchi Y et al (2011) Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum 63:2436\u20132444","journal-title":"Arthritis Rheum"},{"key":"8476_CR25","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ndt\/gfq558","volume":"26","author":"C Bigler","year":"2011","unstructured":"Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M (2011) Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Nephrol Dial Transplant 26:1220\u20131228","journal-title":"Nephrol Dial Transplant"},{"key":"8476_CR26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","volume":"12","author":"M Gatto","year":"2013","unstructured":"Gatto M, Zen M, Ghirardello A et al (2013) Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12:523\u2013526","journal-title":"Autoimmun Rev"},{"key":"8476_CR27","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.4049\/jimmunol.1001731","volume":"185","author":"DM Santer","year":"2010","unstructured":"Santer DM, Hall BE, George TC et al (2010) C1q deficiency leads to the defective suppression of INF-\u03b1 in response to nucleoprotein containing immune complexes. J Immunol 185:4738\u20134749","journal-title":"J Immunol"},{"key":"8476_CR28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","volume":"6","author":"LE Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280\u2013289","journal-title":"Nat Rev Rheumatol"},{"key":"8476_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-008-8098-6","volume":"37","author":"N Bassi","year":"2009","unstructured":"Bassi N, Zampieri S, Ghirardello A et al (2009) Pentraxins, anti-pentraxin antibodies, and atherosclerosis. Clin Rev Allergy Immunol 37:36\u201343","journal-title":"Clin Rev Allergy Immunol"},{"key":"8476_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00719.x","volume":"227","author":"B Bottazzi","year":"2009","unstructured":"Bottazzi B, Garlanda C, Cotena A et al (2009) The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 227:9\u201318","journal-title":"Immunol Rev"},{"key":"8476_CR31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","volume":"33","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Bottazzi B, Mantovani A et al (2003) Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 33:465\u2013473","journal-title":"Eur J Immunol"},{"key":"8476_CR32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coi.2008.05.004","volume":"20","author":"AA Manfredi","year":"2008","unstructured":"Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A (2008) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20:538\u2013544","journal-title":"Curr Opin Immunol"},{"key":"8476_CR33","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","volume":"272","author":"B Bottazzi","year":"1997","unstructured":"Bottazzi B, Vouret-Craviari V, Bastone A et al (1997) Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 272:32817\u201332823","journal-title":"J Biol Chem"},{"key":"8476_CR34","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.170.3.1466","volume":"170","author":"B Bussolati","year":"2003","unstructured":"Bussolati B, Peri G, Salvidio G, Verzola D, Mantovani A, Camussi G (2003) The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. J Immunol 170:1466\u20131472","journal-title":"J Immunol"},{"key":"8476_CR35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0412.2011.01238.x","volume":"91","author":"RR Hamad","year":"2012","unstructured":"Hamad RR, Eriksson MJ, Berg E, Al Merri A, Al Suwaidi J (2012) Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand 91:50\u201356","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8476-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8476-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8476-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:58Z","timestamp":1559440138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8476-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["8476"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8476-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]}}}